Table 2.
Effect size of adverse events in NAFLD individuals with poor weight perception with reference to NAFLD individuals without poor weight perception.
Unadjusted logistic regression | Multivariate logistic regression † | |||
---|---|---|---|---|
Effect size (95%CI) | p-value | Effect size (95%CI) | p-value | |
Overall mortality | 1.73 (1.52 to 1.97) | <0.001* | 1.18 (1.00 to 1.38) | 0.047* |
CVD mortality | 1.91 (1.61 to 2.27) | <0.001* | 1.33 (1.03 to 1.71) | 0.026* |
MACE | 1.52 (1.35 to 1.70) | <0.001* | 1.21 (1.10 to 1.32) | <0.001* |
Advanced fibrosis | 2.08 (1.71 to 2.53) | <0.001* | 1.30 (1.03 to 1.64) | 0.025* |
NAFLD, Non-alcoholic Fatty Liver Disease; 95%CI, 95% Confidence Interval;
bolded p-value ≤ 0.05 denotes statistical significance; CVD, Cardiovascular Disease; MACE, Major Adverse Cardiac Events; BMI, Body Mass Index;
adjusted for BMI, gender, age, ethnicity, income, exercise, diabetes mellitus.